Navigation Links
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Date:8/28/2008

OSLO, August 28 /PRNewswire-FirstCall/ --

- Results Further Support the Clinical Profile of This Novel Anti-Cancer Agent Under Development to Improve the Survival of Patients With Hormone Refractory Prostate Cancer (HRPC)

Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced that the primary objective of its BC1-03 Phase II pain palliation study was met. The study showed that even single doses of Alpharadin in patients with painful bone metastases could produce increasing clinical benefit with increasing dose. Pain palliation is an important quality of life benefit in metastatic cancer patients. The trial also confirmed Alpharadin's benign side-effect profile and, importantly for a drug in this clinical setting, no significant bone marrow toxicity was observed.

In men with HRPC life expectancy can be as short as 18 months, and it is estimated that 100,000 men in the EU and USA die from the disease each year. In 85% of these men the tumor will have spread into the bones. These metastases are a significant problem as they can cause intractable and debilitating pain as well as contributing to a further reduction in life expectancy.

The BC1-03 study was a double-blind randomised pain control study comparing the palliative effects of four different single dose levels of Alpharadin in patients with bony metastatic HRPC. The drug was given by i.v. injection mainly on an outpatient basis. The palliative efficacy of Alpharadin was measured using an assessment of bone pain as well as the patient's consumption of analgesia. The primary study objective was to investigate whether there was a dose-response relationship with respect to pain palliation in this patient group. The study has shown the beneficial palliative effect of a single dose of Alpharadin and that there is a clear dose-response effect, with higher doses providing better pain relief.

The study also showed a dose-dependent reduction in bone al
'/>"/>

SOURCE Algeta
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
4. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
5. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
6. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
7. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
8. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
9. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
10. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
11. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  Pacific Medical Data Solutions is excited ... design . The main website, along with the site,s ... new services and content relevant to the medical billing ... design, viewers can now better understand how PMDS products ... and create a more visible platform about medical billing ...
(Date:8/29/2014)... , August 29, 2014 ... participate in the inaugural Tweetchat taking place in ... Worldwide , organised by UBM Live , ... #CPhIChat is a first of its kind global ... across the supply chain, aimed to stimulate conversations ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... Testing Laboratories, Safety and Compliance Services ... Metrics and Revenue Forecasts to 2021, ... http://www.reportlinker.com/p02347353/Testing-Laboratories-Safety-and-Compliance-Services-Industry-US--Analytics-Extensive-Financial-Benchmarks-Metrics-and-Revenue-Forecasts-to-2021-NAIC-541380 .html Testing ...
Breaking Medicine Technology:PMDS Announces New Website 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... YORK, Oct. 6, 2011 Reportlinker.com announces ... available in its catalogue: ... Global Markets http://www.reportlinker.com/p0298005/Medical-Magnetic-Resonance-Imaging-MRI-Technologies-and-Global-Markets.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... reimbursement changes and the economic downturn have ...
... Scripts, Inc. (Nasdaq: ESRX ) has historically ... results.  This guidance is based on a variety of ... Company,s various filings and releases, actual results may differ ... guidance for a variety of reasons. ...
Cached Medicine Technology:Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 2Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 3Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 4Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 5Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 6Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 7Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 8Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 9Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 10Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets 11Express Scripts Announces Revised 2011 Financial Guidance 2Express Scripts Announces Revised 2011 Financial Guidance 3Express Scripts Announces Revised 2011 Financial Guidance 4Express Scripts Announces Revised 2011 Financial Guidance 5Express Scripts Announces Revised 2011 Financial Guidance 6Express Scripts Announces Revised 2011 Financial Guidance 7Express Scripts Announces Revised 2011 Financial Guidance 8Express Scripts Announces Revised 2011 Financial Guidance 9Express Scripts Announces Revised 2011 Financial Guidance 10
(Date:8/30/2014)... (PRWEB) August 30, 2014 Market ... Industry, 2009-2019 is a professional and in-depth market ... The report firstly reviews the basic information of ... technology. The report then explores global and China’s ... specification, capacity, production value, and market share etc. ...
(Date:8/30/2014)... August 30, 2014 Serving contented clients ... India, Profit By Outsourcing is now offering discount ... The company gives emphasize on putting forward the best ... to clients. Their dedicated team of professionals and web ... They can handle even the critical issues of web ...
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... consolidated litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ... the company’s request to sever four cases selected ... to an Order issued on August 18, 2014, ... Southern District of West Virginia disagrees with Boston ...
(Date:8/30/2014)... Transvenous lead extraction (TLE) is clinically successful in more ... European Lead Extraction ConTRolled (ELECTRa) registry presented for the ... Maria Grazia Bongiorni, chair of the registry,s executive committee. ... electronic devices (CIED) implant procedures has grown in recent ... has increased and leads are often the cause. TLE ...
(Date:8/30/2014)... 30, 2014 In today’s world, a ... difficult to get. Snoring and sleep apnea (a medical ... stops) robs people and their bed partners of the ... to 45% of the population snores and 20 million ... Of these, only 10% have been diagnosed and treated; ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... News) -- Obese patients are more likely than other patients ... they,re diagnosed with the disease, a new study has found. ... States and most of that increase is due to papillary ... University of California-Los Angeles David Geffen School of Medicine. ...
... MONDAY, May 21 (HealthDay News) -- Women who exercise vigorously ... report. Psoriasis is an immune disorder that causes inflammation ... for up to three hours a week can potentially reduce ... said. "Exercise is a modifiable risk factor. Here is ...
... Scientists at Kessler Foundation are presenting findings of ... Hilton San Diego Bayfront in San Diego, CA, May ... Goverover are addressing the Fourth Cooperative Meeting of ... Americas Committee for Treatment and Research (ACTRIMS) . ,This ...
... Behavioral support from peers and primary care office staff can ... as starting a new drug, a new study found. Barbara ... Antonio, is the senior author. The randomized, controlled trial ... peers and primary care office staff could benefit African-American ...
... (HealthDay News) -- Heart damage can be present in obese teens ... study found. Obesity is a risk factor for heart disease, ... their hearts. In the new study, researchers examined the heart ... and 32 obese -- with no symptoms of heart disease. ...
... a new technique for reconstructing the larynx after surgery ... of Otology, Rhinology and Laryngology , they describe how ... donors to replace removed larynx tissue allowed patients ... swallowing function with no need for immunosuppressive medications. ...
Cached Medicine News:Health News:Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 3Health News:Kessler Foundation scientists present cognitive research findings at MS dual symposium 2Health News:Behavioral support from peers, staff lowers patients' blood pressure 2Health News:Behavioral support from peers, staff lowers patients' blood pressure 3Health News:Obese Teens Can Have Heart Damage Without Showing Signs 2Health News:Donor aortic graft improves reconstruction after partial laryngectomy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: